横断不平等在一般和中心肥胖症:横断的英国生物库研究
Joseph Hutchinson1, Natalie Darko2, Rebecca Hardy3
1School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK. j.Hutchinson@lboro.ac.uk.
International journal of obesity (2005)
|January 6, 2026
概括
交叉不平等显著影响身体质量指数 (BMI) 和肥胖. 了解贫困和人口统计学的这些综合影响对于有效的卫生政策至关重要.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 健康的社会决定因素
背景情况:
- 个人和社区的贫困相交,可能会对健康产生独特的影响.
- 我们对这些综合性贫困如何影响人口统计学中的一般和中心肥胖症的理解有限.
研究的目的:
- 调查个人和社区贫困对肥胖的交叉不平等.
- 分析这些与肥胖相关的不平等现象的人口变化.
主要方法:
- 利用了来自452,339名参与者的英国生物库数据.
- 根据收入,社区贫困,性别,种族和年龄,将个人分为320个层.
- 应用多层次分析来评估BMI,脂肪质量指数 (FMI) 和腰与身高比率 (WHtR) 的不平等.
主要成果:
- 交叉不平等解释了总变化的6.5% (BMI),25.2% (FMI) 和9.1% (WHtR).
- 互动效应占这种不平等的 26.5%.
- 确定了特定的模式,例如,富裕的白人女性有优势,而贫困的黑人女性面临不利因素;男性经历了反向关系.
结论:
- 肥胖变化的很大一部分与交叉不平等有关,具有显著的交互组件.
- 政策干预必须考虑这些交叉效应,以防止失败并有效地针对高风险群体.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Bias in Epidemiological Studies
1.3K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K


